Erbitus prolongs life expectancy for lung cancer patients: study (AFP)

[riky]

Erbitus prolongs life expectancy for lung cancer patients: study
    (AFP)

 


<p>You are not allowed to view links. Register or LoginAFP - The cancer drug Erbitux (cetuximab) prolonged the lives of patients with advanced lung cancer by five weeks, according to a clinical study described Sunday as an important gain for such individuals.</p><br clear="all"/>


You are not allowed to view links. Register or Login/news.yahoo.com/s/afp/20080602/hl_afp/ushealthcancer